NasdaqCM - Nasdaq Real Time Price USD

INVO Bioscience, Inc. (INVO)

Compare
1.1100 -0.1300 (-10.48%)
As of 12:18 PM EDT. Market Open.
Loading Chart for INVO
DELL
  • Previous Close 1.2400
  • Open 1.1900
  • Bid 1.0600 x 100
  • Ask 1.1500 x 100
  • Day's Range 1.0000 - 1.2399
  • 52 Week Range 0.5000 - 3.5000
  • Volume 2,772,698
  • Avg. Volume 1,046,968
  • Market Cap (intraday) 4.336M
  • Beta (5Y Monthly) 1.44
  • PE Ratio (TTM) 1.61
  • EPS (TTM) 0.6900
  • Earnings Date Nov 11, 2024 - Nov 15, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.

www.invobioscience.com

25

Full Time Employees

December 31

Fiscal Year Ends

Recent News: INVO

View More

Performance Overview: INVO

Trailing total returns as of 10/15/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

INVO
17.78%
S&P 500
22.39%

1-Year Return

INVO
61.81%
S&P 500
34.90%

3-Year Return

INVO
98.59%
S&P 500
31.54%

5-Year Return

INVO
99.41%
S&P 500
76.36%

Compare To: INVO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: INVO

View More

Valuation Measures

Annual
As of 10/14/2024
  • Market Cap

    4.78M

  • Enterprise Value

    16.72M

  • Trailing P/E

    1.77

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.59

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.90

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -122.80%

  • Return on Assets (ttm)

    -26.57%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    5.77M

  • Net Income Avi to Common (ttm)

    -7.08M

  • Diluted EPS (ttm)

    0.6900

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    942.93k

  • Total Debt/Equity (mrq)

    394.32%

  • Levered Free Cash Flow (ttm)

    1.44M

Research Analysis: INVO

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 1.84M
Earnings -2.25M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Company Insights: INVO

People Also Watch